Redefining Statistical Significance For Rare Disease Research

Christian Schneider | Head of Biopharma Excellence

Biopharma Excellence recently convened three experts in the world of rare disease in a roundtable to discuss the emerging approaches to data collection when patient populations are very small. Their discussion has been summarized for In Vivo.

Start a conversation today